📰 Opgen News
Page 6 - Opgen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Opgen. Real-time updates on events, politics, business and more.
August 4, 2023
StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report released on Monday morning. The brokerage issued a hold rating on the medical research company’s stock. OpGen Stock Down 1.2 % Shares of NASDAQ OPGN opened at $0.58 on Monday. OpGen has a 52-week low of $0.53 and a 52-week […]
July 19, 2023
StockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a report issued on Saturday. The firm issued a hold rating on the medical research company’s stock. OpGen Stock Performance Shares of OPGN stock opened at $0.65 on Friday. The stock has a market cap of $3.58 million, a PE ratio of -0.05 […]
July 17, 2023
StockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Get Free Report) in a report issued on Saturday. The brokerage set a “hold” rating on the medical research company’s stock. OpGen Price Performance Shares of OPGN opened at $0.83 on Friday. OpGen has a twelve month low of $0.54 and a twelve month high of […]
July 3, 2023
OpGen, Inc. (NASDAQ:OPGN – Free Report) was the target of a large increase in short interest in June. As of June 15th, there was short interest totalling 410,100 shares, an increase of 52.5% from the May 31st total of 268,900 shares. Based on an average daily trading volume, of 274,300 shares, the short-interest ratio is […]
June 1, 2023
OpGen Corporate Overview June 1, 2023 OpGen, Inc. ... | June 1, 2023
May 26, 2023
JPMorgan Chase & Co. started coverage on shares of Precigen (NASDAQ:PGEN – Get Rating) in a report released on Tuesday morning, The Fly reports. The brokerage issued a neutral rating on the biotechnology company’s stock. PGEN has been the subject of a number of other research reports. HC Wainwright reaffirmed a buy rating and issued […]
May 26, 2023
JPMorgan Chase & Co. started coverage on shares of Precigen (NASDAQ:PGEN – Get Rating) in a research report sent to investors on Tuesday morning, The Fly reports. The brokerage issued a neutral rating on the biotechnology company’s stock. A number of other equities analysts also recently weighed in on the stock. StockNews.com started coverage on […]
May 25, 2023
Investment analysts at JPMorgan Chase & Co. initiated coverage on shares of Precigen (NASDAQ:PGEN – Get Rating) in a research report issued to clients and investors on Tuesday, The Fly reports. The brokerage set a “neutral” rating on the biotechnology company’s stock. A number of other equities analysts have also issued reports on PGEN. HC […]
May 24, 2023
OpGen, Inc. (NASDAQ:OPGN – Get Rating) – Analysts at Edison Inv. Res issued their FY2023 earnings estimates for OpGen in a note issued to investors on Wednesday, May 17th. Edison Inv. Res analyst A. Aatkar forecasts that the medical research company will earn ($3.39) per share for the year. The consensus estimate for OpGen’s current […]
May 20, 2023
StockNews.com upgraded shares of OpGen (NASDAQ:OPGN – Get Rating) from a sell rating to a hold rating in a report issued on Tuesday. OpGen Stock Up 7.9 % OPGN stock opened at $0.75 on Tuesday. The company has a quick ratio of 0.88, a current ratio of 1.24 and a debt-to-equity ratio of 0.58. The […]